Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AKBhatiaMD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AKBhatiaMD
-
Ankit Bhatia proslijedio/la je Tweet
Great examples of design thinking for doctors and nurses. Having the users design innovations for their needs is seemingly obvious, but so rarely done. Our
#healthcareinnovationlab is trying to change that! https://buff.ly/2KLVJNc@BJC_HealthCare@WUSTLmed@HIPSInnovatorsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Its incredible that this paper didn't receive more press- "afterload reduction" doesn't help in acute HF. Given continued negative trials, why are we fixated on the concept? Comprehensive Vasodilation vs Usual Care in AHFhttps://ja.ma/38WIQLA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Fantastic time celebrating Brian Pierce with our first annual Bruce Protocol Challenge!
#WashUCards@akates1@prathakker@KBerlacher@EmilyGuhlpic.twitter.com/bK5L8bJjEz
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Are you familiar with the cardio-metabolic-renal benefits of
#SGLT2I? Drs.@ZelnikerThomas and Eugene Braunwald summarize mechanisms of SGLT2i in the first of a two-part#JACC State-of-the-Art Review. https://bit.ly/2TZuLZC pic.twitter.com/4lezZ2iZ8U
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Thrilled to share our manuscript published in
@CircAHA today - Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial | Circulation https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.119.044183#.Xi8o5hgtTXw.twitter …pic.twitter.com/bwodnfgn5d
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
What to do with the pt with HF-REF and worsening renal function on RAAS inhibitor(s)? Advice in one slide, designed using guidance from a great open-access
@Heart_BMJ paper by@mrtheprof et al. https://heart.bmj.com/content/105/12/904 …pic.twitter.com/y5jtY0l3cG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
#JACCHF Editor-in-Chief Dr.@coconnormd, alongside Drs.@gcfmd,@kejoynt@mfiuzat et al. provide their insights on the Hospital Readmissions Reduction Program's performance and recommedations for its future. https://bit.ly/2FRQ2fn pic.twitter.com/pdGq3N7UgY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Why we don’t settle when EF improves with
#GDMT and devices. Set your eye on the cure for#HeartFailure - Dr. Doug Mann.@UCARS_recoverypic.twitter.com/IHEyvaxkkX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
A Cardio-Obstetric Approach to Management of the Complex Pregnant Cardiac Patient | JACC: Case Reports
#teamwork#collaboration @NanRaghuraman @jchenkelly @AmandaKVerma @MinnowWalsh @cardioPCImom https://casereports.onlinejacc.org/content/2/1/86Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
MOMENTUM 3 analysis shows arbitrary categorizations based on current or future transplant eligibility should be abandoned for use of left ventricular assist devices.
@BrighamResearch@BrighamFellows@NirUrielMD@mvaduganathan@JAMACardiohttps://ja.ma/2uS8VNcHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
"Innovation is to Repurpose, Reshape and Reinvent" - new
#ACCInnovation Council member@FabioLimaMD "Do not blend into the crowd... Ask the questions no one else is asking. You may not be right, but you will be part of the conversation." https://www.acc.org/membership/sections-and-councils/health-care-innovation-section/section-updates/2020/01/14/24/42/innovation-is-to-repurpose-reshape-and-reinvent …@allheart_mdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Good times at
#CES2020. Our panel unpacked the tricky nature of healthcare and tech partnerships. Lots of potential, but important to do it right.@BJC_HealthCare@WUSTLmed@ACCinTouch@MyiaHealth@amymcdonough@FitbitHealth@MarcWillard@Humana#healthcareinnovationlabpic.twitter.com/fsaBzPbSpi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Validity of EF aside, how do we think about
#HeartFailure in the grey area of EF 40-49%? HFrEF lite? HFpEF-ish? It’s own entity? Great review@JeffHsuMD@gcfmd!@UCSFIMChiefs@SFGH_Chiefs@UCSF_VAChiefshttps://link.springer.com/article/10.1007/s11897-019-00451-0?wt_mc=Internal.Event.1.SEM.ArticleAuthorOnlineFirst&utm_source=ArticleAuthorContributingOnlineFirst&utm_medium=email&utm_content=AA_en_06082018&ArticleAuthorContributingOnlineFirst_20200111 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Ankit Bhatia proslijedio/la je Tweet
BALL GAME. 'Cuse goes on the road to down Virginia.pic.twitter.com/MZS8g1CQup
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Thanks Katie! This is a great way to remember such a special person. Wash U is all in!
@husainim@AKBhatiaMD@prathakker@brittmarieMD@nfrogge@DrRachitaEP@thedanielkfox@WashU_cardshttps://twitter.com/KBerlacher/status/1215729153443536898 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
In a trial, patients who had undergone successful TAVR were assigned to rivaroxaban or antiplatelet therapy. In this substudy in patients who underwent CT, leaflet thickening and reduced leaflet motion at 90 days were less common with rivaroxaban. https://nej.md/2ObQysn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ankit Bhatia proslijedio/la je Tweet
Did you know it’s possible to make cardiac
#amyloidosis diagnosis using#CMR without gadolinium-based contrast agents? In this#JACCIMG paper, authors proposed a diagnostic algorithm for non-contrast CMR for suspected cardiac amyloidosis. https://bit.ly/2SYjc4k pic.twitter.com/BQWFxqosEr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What we have to understand about “surprise bills” is that they are actually just unpaid insurance, based arbitrarily on who is considered “in-network”. We continue to tolerate deceptive payer practices including having hospitals in network but not the doctors who work there.https://twitter.com/wendellpotter/status/1214590242667278336 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
